Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Role of DOCK8 in Hyper-inflammatory Syndromes

Mingce Zhang, Remy R. Cron, Niansheng Chu, Junior Nguyen, Scott M. Gordon, Esraa M. Eloseily, T. Prescott Atkinson, Peter Weiser, View ORCID ProfileMark R. Walter, Portia A. Kreiger, View ORCID ProfileScott W. Canna, View ORCID ProfileEdward M. Behrens, View ORCID ProfileRandy Q. Cron
doi: https://doi.org/10.1101/2024.02.20.24303049
Mingce Zhang
1University of Alabama at Birmingham
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Remy R. Cron
1University of Alabama at Birmingham
Roles: high school graduate
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niansheng Chu
2University of Pennsylvania
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junior Nguyen
2University of Pennsylvania
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott M. Gordon
2University of Pennsylvania
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esraa M. Eloseily
3Cincinnati Children’s Hospital Medical Center, Assiut University Faculty of Medicine
MD, MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Prescott Atkinson
1University of Alabama at Birmingham
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Weiser
1University of Alabama at Birmingham
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark R. Walter
1University of Alabama at Birmingham
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark R. Walter
Portia A. Kreiger
2University of Pennsylvania
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott W. Canna
2University of Pennsylvania
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Scott W. Canna
Edward M. Behrens
2University of Pennsylvania
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Edward M. Behrens
Randy Q. Cron
1University of Alabama at Birmingham
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Randy Q. Cron
  • For correspondence: randycron{at}uabmc.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background Cytokine storm syndromes (CSS), including hemophagocytic lymphohistiocytosis (HLH), are increasingly recognized as hyper-inflammatory states leading to multi-organ failure and death. Familial HLH (FHL) in infancy results from homozygous genetic defects in perforin-mediated cytolysis by CD8 T-lymphocytes and natural killer (NK) cells. Later onset CSS are frequently associated with heterozygous defects in FHL genes, but genetic etiologies for most are unknown. We identified rare DOCK8 variants in CSS patients.

Objective We explore the role of CSS patient derived DOCK8 mutations on cytolytic activity in NK cells. We further study effects of Dock8-/- in murine models of CSS.

Methods DOCK8 cDNA from 2 unrelated CSS patients with different missense mutations were introduced into human NK-92 NK cells by foamy virus transduction. NK cell degranulation (CD107a), cytolytic activity against K562 target cells, and interferon-gamma (IFNγ) production were explored by flow cytometry (FCM). A third CSS patient DOCK8 mRNA splice acceptor site variant was explored by exon trapping. Dock8-/- mice were assessed for features of CSS (weight loss, splenomegaly, hepatic inflammation, cytopenias, and IFNγ levels) upon challenge with lymphochoriomeningitic virus (LCMV) and excess IL-18.

Results Both patient DOCK8 missense mutations decreased cytolytic function in NK cells in a partial dominant-negative fashion in vitro. The patient DOCK8 splice variant disrupted mRNA splicing in vitro. Dock8-/- mice tolerated excess IL-18 but developed features of CSS upon LCMV infection.

Conclusion Mutations in DOCK8 may contribute to CSS-like hyper-inflammatory states by altering cytolytic function in a threshold model of disease.

Key Messages

  • Heterozygous missense mutations in DOCK8 may contribute to decreased NK cell function via partial dominant-negative effects on perforin-mediated cytolysis.

  • Heterozygous mutations in DOCK8 may contribute to hyper-inflammatory syndromes in a threshold model of disease.

  • LCMV infection of Dock8-/- mice recapitulates features of murine FHL.

Capsule Summary Heterozygous missense and splice site mutations in DOCK8 may contribute to hyper-inflammation in patients with CSS. DOCK8 is important for optimal NK cell cytolytic function, and LCMV infection of Dock8-/- mice resembles murine FHL.

Competing Interest Statement

R.Q.C. and E.M.B. have received clinical trial grant support and consulting fees from Sobi (manufacturer of anakinra). R.Q.C. and S.W.C. received speaking fees from Sobi and Practicepoint, CME. There are no other relevant financial disclosures.

Funding Statement

The work was supported by grants from the Histiocytosis Association (to R.Q.C.), the Kaul Pediatric Research Institute (to R.Q.C.), NIH R01-HD-098428 (to S.W.C.), and NIH R01-AI-121250-A1 (to E.M.B.).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study (IRB-120907003) was approved by the University of Alabama Institutional Review Board.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • The work was supported by grants from the Histiocytosis Association (to R.Q.C.), the Kaul Pediatric Research Institute (to R.Q.C.), NIH R01-HD-098428 (to S.W.C.), and NIH R01-AI-121250-A1 (to E.M.B.).

Data Availability

All data produced in the present work are contained in the manuscript.

  • Abbreviations used

    CSS
    cytokine storm syndrome
    DOCK8
    dedicator of cytokinesis 8
    FV
    foamy virus
    HIS
    hyper-inflammatory syndrome
    HLH
    hemophagocytic lymphohistiocytosis
    IBD
    inflammatory bowel syndrome
    LCMV
    lymphocytic choriomeningitis virus
    MAS
    macrophage activation syndrome
    NK
    natural killer
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted February 23, 2024.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Role of DOCK8 in Hyper-inflammatory Syndromes
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Role of DOCK8 in Hyper-inflammatory Syndromes
    Mingce Zhang, Remy R. Cron, Niansheng Chu, Junior Nguyen, Scott M. Gordon, Esraa M. Eloseily, T. Prescott Atkinson, Peter Weiser, Mark R. Walter, Portia A. Kreiger, Scott W. Canna, Edward M. Behrens, Randy Q. Cron
    medRxiv 2024.02.20.24303049; doi: https://doi.org/10.1101/2024.02.20.24303049
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Role of DOCK8 in Hyper-inflammatory Syndromes
    Mingce Zhang, Remy R. Cron, Niansheng Chu, Junior Nguyen, Scott M. Gordon, Esraa M. Eloseily, T. Prescott Atkinson, Peter Weiser, Mark R. Walter, Portia A. Kreiger, Scott W. Canna, Edward M. Behrens, Randy Q. Cron
    medRxiv 2024.02.20.24303049; doi: https://doi.org/10.1101/2024.02.20.24303049

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Allergy and Immunology
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)